ClariVest Asset Management’s Global Cord Blood Corporation CO Stock Holding History

ClariVest Asset Management’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-51,392	Closed	-$317K	–	678
2015 Q2	$317K	Sell	51,392 -3,413	-6%	-$21K	0.01%	369
2015 Q1	$280K	Hold	54,805	–	–	0.01%	375
2014 Q4	$247K	Sell	54,805 -7,050	-11%	-$33.5K	0.01%	321
2014 Q3	$302K	Buy	61,855 +1,792	+3%	+$8.69K	0.01%	315
2014 Q2	$332K	Buy	+60,063	New	+$270K	0.01%	314

Other funds holding CO

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

ClariVest Asset Management's CO Position: Q3 2015 in Review

ClariVest Asset Management sold out of Global Cord Blood Corporation (CO) in Q3 2015, closing a stake of 51,392 shares — an estimated $317K sold.

ClariVest Asset Management first reported a position in CO in Q2 2014 and held it in 5 quarters. The position peaked at $332K in Q2 2014. 36 funds tracked by Wall St. Rank hold CO as of Q3 2015.

ClariVest Asset Management reported no remaining Global Cord Blood Corporation position as of Q3 2015 after selling out during the quarter.
ClariVest Asset Management sold 51,392 Global Cord Blood Corporation shares in Q3 2015, an estimated $317K.
ClariVest Asset Management first reported a position in Global Cord Blood Corporation in Q2 2014 and held it in 5 quarters.
ClariVest Asset Management's Global Cord Blood Corporation position peaked at $332K in Q2 2014.
36 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2015.

Based on ClariVest Asset Management's 13F filing for Q3 2015, filed 26 Oct 2015.